Vaccines

Eliminating infectious diseases that lead to blindness in Africa – an eye-opening view from the frontlines featuring Sightsavers.

How are industry and academia collaborating to tackle neglected diseases?

Researcher at the Wyss Institute have developed a biomaterial-based vaccine that reportedly eliminates acute myeloid leukemia.

As the new virus spreads, more information is needed to mount an appropriate response.

Cures for all presents a real focus for the next decade – but companies must be rewarded for their work.

The EMA has granted conditional marketing approval for Ervebo, the first vaccine to protect against Ebola.

Researchers capture the interactions of antibodies with the parasite responsible for malaria for the first time

David Walker discusses the threat of bioterrorism and the importance of basic research.

Emergent Biosolutions, has become a multinational biopharma company, despite working in some difficult therapeutic areas including biodefense.

A single vector vaccine has been developed that could offer protection against tularemia, anthrax, plague and melioidosis.